
Nippon India Pharma Fund - Direct Plan - Growth Plan
Add To Comparepreviously known as Reliance Pharma Dir Gr until
NAV on July 21, 2025
Category
Equity:
Sector - Healthcare
Sector - Healthcare
Investment StyleBox
Large Growth
Total Assets
8,569 cr
Turnover Ratio
16.09%
Expense Ratio
0.89%
Exit Load
1.00%
if redeemed within
Returns
- 1M: 3.19%
- 1Y: 14.55%
- 3M: 6.29%
- 3Y: 25.26%
- 6M: 6.18%
- 5Y: 22.98%
Best Sector Healthcare Funds
NAME | LATEST NAV |
RETURNS 1y |
FUND ASSETS |
Expense RATIO |
RISK | |
503.704 | 20.64% | 3,849 cr | 0.89% | - |
Other plans of Nippon India Pharma